Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Stage

Series A - II | Alive

Total Raised

$34M

Last Raised

$16M | 13 yrs ago

About Vivendy Therapeutics

Vivendy Therapeutics, a start-up pharmaceutical company founded in March 2006, is focused on the development of an enzyme replacement therapy (ERT) for the treatment of Morbus Morquio (Mucopolysaccharidosis (MPS) IVA), a rare lysosomal storage disease

Vivendy Therapeutics Headquarter Location

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vivendy Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vivendy Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.